Cipta Sarana Medika Tbk. vs Reksa Dana Indeks Capital ETF IDX ESG Leaders — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B, 3.92M 24h volume), while Reksa Dana Indeks Capital ETF IDX ESG Leaders trades at Rp84 (market cap 8.65B, 150K 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 18.9× Reksa Dana Indeks Capital ETF IDX ESG Leaders's market cap, and Cipta Sarana Medika Tbk. is more actively traded (3.92M versus 150K). Which is the better fit depends on your goals.
| DKHH | XCEG | |
|---|---|---|
Market Cap | 163.22B | 8.65B |
Volume | 3.92M | 150K |
Lot | 39.16K | 1.5K |
Turnover | 249.6M | 12.6M |
Average Price | 63.74 | 84 |
Value | 249.6M | 12.6M |
Indicative Equilibrium Price | 64 | — |
Indicative Equilibrium Volume | 77 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →